CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Virtual Peer Support PlatformWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug639 Control Period Wiki 1.00
drug647 Convalescent Plasma Wiki 0.22

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D000077062 Burnout, Psychological NIH 0.30

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 The Role of Virtual Peer Support Platforms for Reducing Stress and Burnout Among Frontline Healthcare Workers During COVID-19: A Randomized Controlled Trial

Physician burnout has a significant impact on the wellness and productivity of physicians as well as patient health outcomes. Managing burnout among frontline workers is critical to Canada's response to the COVID-19 pandemic, in order to support frontline workers and reduce inefficiencies and medical errors frequently linked to burnout, ultimately improving our ability to detect, treat and manage COVID-19 cases. Therefore, this trial aims to assess the effects of an 8-session intervention over 3 months for burnout in physician residents in residency programs in Canada and the United States of America during the COVID-19 pandemic. This trial will provide evidence to inform health system management and public health response early and effectively so as to maintain the integrity of our workforce during and post-pandemic. The virtual delivery platform renders the proposed intervention easily disseminated internationally, in low- middle- and high- income countries and across urban and rural cities.

NCT04474080 Burnout Behavioral: Virtual Peer Support Platform Behavioral: Control Period
MeSH:Burnout, Psychological

Primary Outcomes

Description: Maslach Burnout Inventory (MBI) will be administered to measure overall burnout. The MBI is a 22-item measure of the three dimensions of burnout: emotional exhaustion (EE), depersonalization (DP) and lack of personal accomplishment (PA) on a 7-point Likert scale ranging from 0 to 6. High scores on EE (≥26) or DP (≥9), and low scores on PA (≤34) are indicative of burnout.

Measure: Assess and measure overall burnout

Time: Change from baseline at month 3 and 6.

Secondary Outcomes

Description: Instrument/method of measurement: Stress will be measured using the Perceived Stress Scale, a 10-item scale ranging from 0-4 representing never to very often, with total scores between 0-40.

Measure: Assess stress

Time: Change from baseline at month 3 and 6.

Description: depression will be measured using a feasible two question approach developed by Spitzer et. al, validated by Whooley et. al.

Measure: Assess depression

Time: Change from baseline at month 3 and 6.

Description: Instrument/method of measurement: Single item linear analog scale. A score of 5 or less on this scale has known association with poor outcomes across clinical research of burnout.

Measure: Assess quality of life

Time: Change from baseline at month 3 and 6.


No related HPO nodes (Using clinical trials)